Mettler-Toledo International (NYSE:MTD) Price Target Raised to $1,285.00

Mettler-Toledo International (NYSE:MTD) had its price objective hoisted by JPMorgan Chase & Co. from $1,200.00 to $1,285.00 in a report released on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the medical instruments supplier’s stock.

Other research analysts also recently issued research reports about the stock. Barclays increased their price target on shares of Mettler-Toledo International from $1,325.00 to $1,350.00 and gave the company an “overweight” rating in a report on Thursday, October 2nd. Evercore ISI increased their price target on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the company an “outperform” rating in a report on Tuesday, October 7th. Bank of America increased their price target on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a report on Monday, September 22nd. Citigroup increased their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Thursday, August 21st. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday. Five investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $1,336.50.

Mettler-Toledo International Stock Down 2.5%

MTD opened at $1,274.39 on Thursday. The firm has a 50-day simple moving average of $1,278.97 and a two-hundred day simple moving average of $1,190.05. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,486.76. The company has a market capitalization of $26.25 billion, a PE ratio of 32.27, a price-to-earnings-growth ratio of 3.82 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 EPS for the quarter, beating the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the firm earned $9.65 EPS. The business’s revenue was up 3.9% on a year-over-year basis. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, sell-side analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Shawn Vadala sold 300 shares of the firm’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $1,325.00, for a total transaction of $397,500.00. Following the transaction, the chief financial officer directly owned 5,095 shares of the company’s stock, valued at approximately $6,750,875. This trade represents a 5.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gerry Keller sold 165 shares of the firm’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the transaction, the insider directly owned 94 shares in the company, valued at approximately $123,012.16. This trade represents a 63.71% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 1.94% of the stock is owned by company insiders.

Hedge Funds Weigh In On Mettler-Toledo International

A number of institutional investors have recently modified their holdings of MTD. UMB Bank n.a. increased its position in shares of Mettler-Toledo International by 13.4% during the first quarter. UMB Bank n.a. now owns 144 shares of the medical instruments supplier’s stock worth $170,000 after acquiring an additional 17 shares during the period. Park Avenue Securities LLC increased its position in shares of Mettler-Toledo International by 7.2% during the first quarter. Park Avenue Securities LLC now owns 297 shares of the medical instruments supplier’s stock worth $351,000 after acquiring an additional 20 shares during the period. Farther Finance Advisors LLC increased its position in shares of Mettler-Toledo International by 39.1% during the first quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier’s stock worth $103,000 after acquiring an additional 25 shares during the period. GAMMA Investing LLC increased its position in shares of Mettler-Toledo International by 11.2% during the first quarter. GAMMA Investing LLC now owns 327 shares of the medical instruments supplier’s stock worth $386,000 after acquiring an additional 33 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in shares of Mettler-Toledo International by 43.4% during the first quarter. Assenagon Asset Management S.A. now owns 55,504 shares of the medical instruments supplier’s stock worth $65,545,000 after acquiring an additional 16,787 shares during the period. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.